“Despite all the work, there was still plenty of room for joyful anticipation thanks to the professionalism of SIX and the warm reception we got,” the CEO of Xlife Sciences continues enthusiastically. “At no time did SIX ever try to sell us anything. Instead, right from the outset SIX was a sparring partner that was just as much a part of our team as our lawyers and our house bank are. We encountered not just a product completely free of teething issues, but also a veritable ecosystem for startups and SMEs.”
SIX, in fact, offers future issuers e-learning courses and workshops, and operates supportive programs such as Stage, which raises a company’s visibility through independent equity research, and Bridge, which connects issuers with investors.
“I highly recommend to any company that wants to grow or increase its name recognition to get in contact with SIX as early on as possible and to utilize the tools that SIX provides. At the same time, we at Xlife Sciences are willing to share our experiences with other SMEs and startups,” Baumann emphasizes, coming across like a real ambassador for Sparks. “We are happy to do that – our role as a pioneer obliges us,” he says with enthusiasm.
It’s quite possible that Baumann himself will soon bring about additional listings on Sparks because the business model being pursued by Xlife Sciences is diversified also in terms of exit scenarios. Besides the possibility of selling a project company, folding it into a joint venture, or licensing patents, listing it on an appropriate stock exchange is likewise conceivable.